DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Moayyedi P, Eikelboom JW, Bosch J. et al.
Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.
Gastroente 2019;
157: 682-91. e2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.